![Mario Filion](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mario Filion
Oprichter bij Alethia Biotherapeutics, Inc.
Profiel
Mario Filion is the founder of Alethia Biotherapeutics, Inc., which was founded in 2002.
He currently holds the title of Chief Scientific Officer & Executive VP at the company.
Dr. Filion also held the position of Director-Molecular Genetics at Fortaleza Energy, Inc. and President-Clinical Genomics Division at SignalGene, Inc. In terms of education, Dr. Filion obtained a doctorate degree from the University of Montréal.
Actieve functies van Mario Filion
Bedrijven | Functie | Begin |
---|---|---|
Alethia Biotherapeutics, Inc.
![]() Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Oprichter | 20-07-2009 |
Eerdere bekende functies van Mario Filion
Bedrijven | Functie | Einde |
---|---|---|
FORTALEZA ENERGY INC. | Corporate Officer/Principal | - |
SignalGene, Inc. | Corporate Officer/Principal | - |
Opleiding van Mario Filion
University of Montréal | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Alethia Biotherapeutics, Inc.
![]() Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
SignalGene, Inc. | |
Fortaleza Energy, Inc.
![]() Fortaleza Energy, Inc. Oil & Gas ProductionEnergy Minerals Fortaleza Energy, Inc. is an oil and gas company, which engages in the exploration, development, and production of crude oil and natural gas. It also provides custom acid blending services for fracture stimulation and production optimization fluids through its wholly owned subsidiary, BlendForce Energy Services Inc. The company was founded on January 15, 2007 and is headquartered in Calgary, Canada. | Energy Minerals |